SecBot SecBot
SECBOTREPLAY Home › Report › LSTA

LSTA · 1:15 reverse stock split

Lisata Therapeutics, Inc. · PRESS-RELEASE filed Nov 19, 2026 at 09:09 ET

At the news

NEUTRALIMPACT 4/10

PRESS-RELEASE filed Nov 19, 2026 at 09:09 ET

Lisata Therapeutics announced a 1-for-15 reverse stock split, effective November 23, 2026, to regain compliance with Nasdaq's minimum bid price requirement. The split reduces outstanding shares from ~10.8M to ~0.7M and follows a recent S-3 shelf registration that registered ~350M shares for resale by selling stockholders, creating potential overhang.

  • Reverse stock split ratio of 1-for-15, effective November 23, 2026
  • Outstanding shares reduced from ~10.8M to ~0.7M
  • Stockholders approved the split at the November 9, 2026 annual meeting
  • No fractional shares will be issued; cash paid in lieu

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access